Fed. Circ. Upholds Endo's PTAB Win In Amneal Patent Fight

By Kelly Knaub ( November 8, 2016, 2:38 PM EST) -- The Federal Circuit on Tuesday affirmed a Patent Trial and Appeal Board decision finding that prior art didn't make Endo Pharmaceuticals Inc.'s patents for the painkiller Opana ER obvious, rejecting Amneal Pharmaceuticals LLC's argument that the board used the incorrect legal standard....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!